Grantham, Mayo, Van Otterloo & Co (GMO)’s Albemarle ALB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALB
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s ALB Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Albemarle (ALB) stake by 1.8% in Q1 2026, selling an estimated $2.8M and leaving 906,683 shares worth $163M. The position accounts for 0.42% of the portfolio, ranked #38.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ALB in Q1 2016 and has held it in 26 quarters since. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 906,683 shares of Albemarle worth $163M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 16,388 Albemarle shares in Q1 2026, an estimated $2.8M.
- Albemarle made up 0.42% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #38 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Albemarle in Q1 2016 and has held it in 26 quarters since.
- 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.